论文部分内容阅读
业绩平稳增长竞争优势明显资产注入进入倒计时当前股价:23.85元今日投资个股安全诊断星级:★★★公司是全国医药行业首家上市公司,公司产品包括西药、中药和保健品等88个品种被认定为高新技术产品。通过一系列的市场运作,目前聚集在哈药品牌麾下的49个优势品种,年销售收入均超过1000万元以上,13个产品年销售收入过亿元。
The performance of steady growth Significant competitive advantage Asset injection into the countdown Current stock price: 23.85 yuan Investment in stocks today, the safety diagnosis Star: ★ ★ ★ company is the first listed company in the pharmaceutical industry, the company’s products, including Western medicine, Chinese medicine and health products, 88 species were Identified as high-tech products. Through a series of market operations, 49 dominant varieties currently gathered under the brand name of Harbin Pharmaceuticals have annual sales revenue of more than 10 million yuan and 13 products with annual sales income of over 100 million yuan.